Professor
Fred Hutchinson Cancer Research Center / Seattle Care Cancer Alliance / University of Washington, Seattle, WA
Disclosure: A2 Biotherapeutics (Individual(s) Involved: Self): Consultant, Other Financial or Material Support, Stock Options; Bioline Rx (Individual(s) Involved: Self): Consultant; Celgene (Individual(s) Involved: Self): Consultant, Grant/Research Support; Gilead (Individual(s) Involved: Self): Consultant; Juno Therapeutics (Individual(s) Involved: Self): Consultant, four pending patents, not issued, licensed, no royalities, no licensees, Other Financial or Material Support, Research Grant or Support; Kite Pharma (Individual(s) Involved: Self): Consultant, Grant/Research Support; Novartis (Individual(s) Involved: Self): Consultant; Pharmacyclics (Individual(s) Involved: Self): Consultant
